​

Doximity (DOCS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DOCS Stock Forecast

Doximity (DOCS) stock forecast, based on 23 Wall Street analysts, predicts a 12-month average price target of $29.47, with a high of $59.00 and a low of $18.00. This represents a 48.46% increase from the last price of $19.85.

$15 $24 $33 $42 $51 $60 High: $59 Avg: $29.47 Low: $18 Last Closed Price: $19.85

DOCS Stock Rating

Doximity stock's rating consensus is Hold, based on 23 Wall Street analysts. The breakdown includes 1 Strong Buy (4.35%), 9 Buy (39.13%), 13 Hold (56.52%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 23 0 13 9 1 Strong Sell Sell Hold Buy Strong Buy

DOCS Price Target Upside V Benchmarks

TypeNameUpside
StockDoximity48.46%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 18.14%

Price Target Trends

1M3M12M
# Anlaysts-1441
Avg Price Target-$24.43$42.56
Last Closing Price$19.85$19.85$19.85
Upside/Downside-23.07%114.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 265512--22
May, 265117--23
Apr, 265135--23
Mar, 265115--21
Feb, 265105-121
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 14, 2026Barclays$20.00$18.0111.05%0.76%
May 14, 2026Jailendra SinghTruist Financial$19.00$17.876.32%-4.28%
May 14, 2026Sean DodgeBMO Capital$20.00$23.39-14.49%0.76%
May 14, 2026Scott BergNeedham$27.00$23.3915.43%36.02%
May 14, 2026Mizuho Securities$26.00$23.3911.16%30.98%
May 14, 2026Canaccord Genuity$30.00$23.3928.26%51.13%
May 14, 2026Goldman Sachs$24.00$23.392.61%20.91%
May 14, 2026Craig HettenbachMorgan Stanley$35.00$23.3949.64%76.32%
May 14, 2026Michael ChernyLeerink Partners$25.00$23.396.88%25.94%
May 14, 2026Wells Fargo$18.00$23.39-23.04%-9.32%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 14, 2026BMO CapitalMarket PerformMarket Performhold
May 14, 2026NeedhamBuyBuyhold
May 14, 2026Morgan StanleyOverweightOverweighthold
May 14, 2026BTIGBuyNeutraldowngrade
May 14, 2026JefferiesBuyHolddowngrade
May 14, 2026KeyBancOverweightSector Weightdowngrade
Feb 06, 2026BTIGBuyBuyhold
Feb 06, 2026NeedhamBuyBuyhold
Feb 06, 2026Piper SandlerOverweightOverweighthold
Jan 30, 2026Bank of America SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$0.81$0.58$0.78$1.19$1.05---
Avg Forecast$0.77$0.70$0.90$1.15$1.26$1.42$1.65$1.76
High Forecast$0.78$0.73$0.91$1.21$1.38$1.82$1.72$1.84
Low Forecast$0.76$0.68$0.88$1.12$1.15$1.17$1.59$1.71
Surprise %5.19%-17.14%-13.33%3.48%-16.67%---

Revenue Forecast

$300M $420M $540M $660M $780M $900M Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$343.55M$419.05M$475.42M$570.40M$644.86M---
Avg Forecast$339.84M$418.16M$473.82M$539.96M$596.32M$657.01M$728.72M$856.10M
High Forecast$344.57M$433.02M$474.06M$543.62M$626.49M$658.14M$754.62M$886.53M
Low Forecast$335.52M$408.11M$473.58M$537.50M$572.44M$655.89M$711.21M$835.53M
Surprise %1.09%0.21%0.34%5.64%8.14%---

Net Income Forecast

$100M $160M $220M $280M $340M $400M Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$154.78M$112.82M$147.58M$223.19M$196.05M---
Avg Forecast$158.06M$143.70M$137.63M$240.13M$260.04M$306.97M$338.64M$362.09M
High Forecast$160.92M$150.34M$165.16M$249.48M$282.92M$373.71M$354.29M$378.82M
Low Forecast$155.45M$139.22M$110.11M$230.77M$237.16M$240.24M$328.06M$350.78M
Surprise %-2.07%-21.49%7.23%-7.05%-24.61%---

DOCS Forecast FAQ

Is Doximity stock a buy?

Doximity stock has a consensus rating of Hold, based on 23 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 9 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Doximity is a neutral investment for most analysts.

What is Doximity's price target?

Doximity's price target, set by 23 Wall Street analysts, averages $29.47 over the next 12 months. The price target range spans from $18 at the low end to $59 at the high end, suggesting a potential 48.46% change from the previous closing price of $19.85.

How does Doximity stock forecast compare to its benchmarks?

Doximity's stock forecast shows a 48.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (18.14%).

What is the breakdown of analyst ratings for Doximity over the past three months?

  • June 2026: 22.73% Strong Buy, 22.73% Buy, 54.55% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 21.74% Strong Buy, 47.83% Buy, 30.43% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 21.74% Strong Buy, 56.52% Buy, 21.74% Hold, 0% Sell, 0% Strong Sell.

What is Doximity’s EPS forecast?

Doximity's average annual EPS forecast for its fiscal year ending in March 2027 is $1.42, marking a 35.24% increase from the reported $1.05 in 2026. Estimates for the following years are $1.65 in 2028, and $1.76 in 2029.

What is Doximity’s revenue forecast?

Doximity's average annual revenue forecast for its fiscal year ending in March 2027 is $657.01M, reflecting a 1.88% increase from the reported $644.86M in 2026. The forecast for 2028 is $728.72M, and $856.1M for 2029.

What is Doximity’s net income forecast?

Doximity's net income forecast for the fiscal year ending in March 2027 stands at $306.97M, representing an 56.58% increase from the reported $196.05M in 2026. Projections indicate $338.64M in 2028, and $362.09M in 2029.